LivaNova (NASDAQ:LIVN) Sets New 1-Year High – Here’s What Happened

LivaNova PLC (NASDAQ:LIVN) shares hit a new 52-week high during trading on Friday . The stock traded as high as $65.95 and last traded at $64.6850, with a volume of 38349 shares traded. The stock had previously closed at $64.71.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Stifel Nicolaus lifted their price target on shares of LivaNova from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, January 7th. KeyCorp initiated coverage on LivaNova in a report on Friday, December 19th. They issued an “overweight” rating and a $81.00 price objective for the company. Mizuho upped their target price on LivaNova from $70.00 to $72.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Robert W. Baird set a $75.00 price target on LivaNova in a research report on Tuesday, December 16th. Finally, Barclays raised their price target on LivaNova from $58.00 to $67.00 and gave the company an “equal weight” rating in a research note on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $69.38.

LivaNova Stock Down 0.1%

The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.12 and a current ratio of 1.33. The firm has a fifty day simple moving average of $62.88 and a 200-day simple moving average of $55.69. The firm has a market cap of $3.53 billion, a price-to-earnings ratio of -16.15 and a beta of 0.97.

Institutional Trading of LivaNova

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Arizona State Retirement System raised its holdings in LivaNova by 1.7% in the 3rd quarter. Arizona State Retirement System now owns 16,129 shares of the company’s stock valued at $845,000 after acquiring an additional 274 shares during the period. Bayforest Capital Ltd grew its position in shares of LivaNova by 44.8% in the third quarter. Bayforest Capital Ltd now owns 918 shares of the company’s stock valued at $48,000 after purchasing an additional 284 shares during the last quarter. State of Michigan Retirement System grew its position in shares of LivaNova by 2.3% in the second quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock valued at $590,000 after purchasing an additional 300 shares during the last quarter. UMB Bank n.a. increased its stake in shares of LivaNova by 63.0% during the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after purchasing an additional 306 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in LivaNova by 182.5% during the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock worth $28,000 after purchasing an additional 407 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.